DPP-4 inhibitor and alpha-glucosidase inhibitor

This page covers all DPP-4 inhibitor and alpha-glucosidase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DPP-4 and alpha-glucosidase.

Targets

DPP-4 and alpha-glucosidase

Phase 2 pipeline (1)

• Alogliptin and voglibose · Takeda · Diabetes
  Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, while voglibose is an alpha-glucosidase inhibitor.

Patent intelligence

• dpp 4 inhibitor and alpha glucosidase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates